OCX

ONCOCYTE
AMEX

Real-time Quotes | Nasdaq Last Sale

1.400
-0.150
-9.68%
After Hours: 1.410 +0.01 +0.71% 17:52 09/18 EDT
OPEN
1.600
PREV CLOSE
1.550
HIGH
1.640
LOW
1.350
VOLUME
2.46M
TURNOVER
--
52 WEEK HIGH
3.510
52 WEEK LOW
1.150
MARKET CAP
94.15M
P/E (TTM)
-2.7419
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average OCX stock price target is 3.100 with a high estimate of 6.00 and a low estimate of 1.500.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About OCX
OncoCyte Corporation is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment. Its initial focus will be confirmatory diagnostics, utilizing liquid biopsy technology, for use in conjunction with imaging to confirm initial diagnoses within certain oncology indications. In addition, it will be developing screening diagnostics as replacements for screening imaging procedures. For some indications, it will also be pursuing the probability of recurrence of a specific cancer through the development of prognostics or companion diagnostics that help a physician determine which therapy is the optimal treatment for the patient. It offers diagnostic tests for lung, breast and bladder cancer.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of OncoCyte Corp stock information, including AMEX:OCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OCX stock methods without spending real money on the virtual paper trading platform.